You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0094 Relationship between disease duration and response to combination etanercept (ETN)-methotrexate (MTX) therapy in subjects with moderately active rheumatoid arthritis

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – prognosis, predictors and outcome
FRI0094 Relationship between disease duration and response to combination etanercept (ETN)-methotrexate (MTX) therapy in subjects with moderately active rheumatoid arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hall S, Szumski A, Koenig A, et al
FRI0094 Relationship between disease duration and response to combination etanercept (ETN)-methotrexate (MTX) therapy in subjects with moderately active rheumatoid arthritis
Annals of the Rheumatic Diseases 2013;71:341.